Skip to main content

Day: March 27, 2025

Oma Savings Bank Plc’s Chief Communications Officer Changes

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 27 MARCH 2025 AT 17.30 P.M EET, CHANGES BOARD/MANAGEMENT/AUDITORS Oma Savings Bank Plc’s Chief Communications Officer Changes Chief Communications Officer of Oma Savings Bank (OmaSp or the Company) Minna Sillanpää will leave the Company as of 27 March 2025. MMM, MBA Pirjetta Soikkeli has been appointed as new Chief Communications Officer, starting on 7 July 2025 at the latest. CEO Sarianna Liiri:“I would like to extend my sincere gratitude to Minna for her long and dedicated service to Oma Savings Bank. Minna has made significant contributions to the development of the Company’s communications, branding, and sustainability efforts”, says interim CEO Sarianna Liiri. Pirjetta Soikkeli joins Oma Savings Bank from the position of Senior Vice President Communications, Marketing and Sustainability...

Continue reading

HUB Announces Reverse Share Split

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) — Hub Cyber Security Ltd. (Nasdaq: HUBC) (“HUB Security” or the “Company”), a global leader in confidential computing and secured data fabric technology, today announced a 1-for-10 reverse share split of its ordinary shares, no par value per share (the “Ordinary Shares”). The reverse share split and corresponding share capital adjustment will become effective at 11:59 p.m. Eastern Time on Friday, March 28, 2025. The Ordinary Shares will begin trading on a split-adjusted basis on The Nasdaq Stock Market LLC (“Nasdaq”) at the open of business on Monday, March 31, 2025, under the existing trading symbol “HUBC,” but the Ordinary Shares will trade under a new CUSIP number, M6000J168. HUB Security’s outstanding warrants will continue to be traded under the symbols “HUBCW” and “HUBCZ”...

Continue reading

Novaturas announces EUR 1 mln. loan

Tour operator Novaturas Group has signed an agreement with Neset Kockar, a strategic investor from Turkey, on granting a loan to the company. Under the agreement, Mr Kockar, who intends to acquire shares in the company, will grant a loan of up to EUR 1 mln. to Novaturas. The short-term loan of up to EUR 1 mln. will be granted to the company for a period ending on 30 June at an annual interest rate of 8.5%. About the company The Novaturas Group is a tour operator offering the widest range of travel destinations from the Baltic States. It has been operating in the region for 25 years. The company offers summer and winter recreational, sightseeing, exotic, skiing, workation and group trips to many destinations worldwide. According to unaudited data, in 2024, Novaturas Group recorded revenues of EUR 201 mln. and served 239 thsnd. passengers...

Continue reading

CPP Announces Acquisition of Ramona Park in Los Angeles County

The project will preserve 49 affordable housing units in Baldwin Park, Calif.Ramona Park, an affordable housing complex in Baldwin Park, Calif.CPP(Community Preservation Partners), a mission-driven affordable housing preservation developer, has announced the acquisition and planned renovation of Ramona Park, an affordable housing complex in Baldwin Park, Calif. This is CPP’s fourth project in the Los Angeles area in the past year.BALDWIN PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) — CPP (Community Preservation Partners), a mission-driven affordable housing preservation developer, has announced the acquisition and planned renovation of Ramona Park, an affordable housing complex in Baldwin Park, Calif. This is CPP’s fourth project in the Los Angeles area in the past year. Ramona Park is located at 13870 Ramona Boulevard...

Continue reading

Ascend Learning Announces Acquisition of Clover Learning to Expand Allied Health Education Offerings

Company continues its investment in advancing healthcare education among students and professionals to address national radiology workforce shortage LEAWOOD, Kan., March 27, 2025 (GLOBE NEWSWIRE) — Ascend Learning, a leading healthcare and learning software company, today announced the acquisition of Clover Learning, a pioneer in online diagnostic imaging education. Clover Learning enhances Ascend’s portfolio of allied health brands, furthering its mission to provide comprehensive training and certification solutions to healthcare professionals. As the US population ages, demand for medical imaging services is increasing and contributing to staffing challenges and shortages in the radiology workforce. Learning and upskilling to aid in retention and attracting new talent are critical needs in this workforce. “We are thrilled to...

Continue reading

Notice on convening the Extraordinary General Meeting of Shareholders of AB Akola Group

NOTICE TO THE SHAREHOLDERS OF AB AKOLA GROUPVilnius, 27 March 2025 Hereby we announce the Extraordinary General Meeting of Shareholders (hereinafter – the Meeting) of AB Akola Group, registered address Subačiaus St. 5, Vilnius, Lithuania, code 148030011, (hereinafter – the Company) is convened. The date, time, and venue of the Meeting – 29 April 2025 at 10.00 a.m., AB Akola Group office, Subačiaus St. 5, Vilnius, Lithuania. The accounting day of the Meeting is 22 April 2025. Only the persons who are the shareholders of the Company at the end of the Accounting day of the Meeting shall have the right to attend and vote at the Meeting. The Rights Accounting Day is 14 May 2025. Only the persons who are the shareholders of the Company at the end of the Rights Accounting day shall have proprietary rights. On the day the Meeting is convened the...

Continue reading

Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025

27 MARCH 2025                PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdańsk, Poland – 27 March 2025 – Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in innovative technology for cancer detection through unique urine sample analysis, plans to initiate clinical trials in the European Union in Q3 2025 for the Panuri project—a diagnostic test for pancreatic cancer. In the coming weeks, Urteste will announce a tender to select a Contract Research Organization (CRO) to conduct the clinical trials. Additionally, the company is scheduled to hold its fourth Q-submission meeting with the FDA in mid-2025 to finalize details ahead of clinical trials in the United States. The European certification study will be conducted in Poland and selected EU countries, involving...

Continue reading

BIC: Release and Availability of the 2024 Universal Registration Document

Release and Availability of the 2024 Universal Registration Document Clichy, France – March 27, 2025 – The 2024 Universal Registration Document (French version) was filed with the A.M.F (Autorité des Marchés Financiers: French Financial Markets Authority) on March 27, 2025. The document is available on BIC’s website in French and English in the Investors’ section under Universal Registration Document as well as on the website of the A.M.F (www.amf-france.org). It is available to the public under current regulatory conditions. The 2024 Universal Registration Document contains XBRL tags (eXtensible Business Reporting Language) for its financial statements, as BIC adopted the European Single Electronic Format (ESEF). The document includes:the Annual Financial Report, the Management report of the Board of Directors for 2024, the Report on...

Continue reading

Oportun Comments on Director Nominations

SAN CARLOS, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, today confirmed receipt of a notice from Findell Capital Management LLC (“Findell”) nominating two directors to stand for election to the Oportun Board of Directors (the “Board”) at the Company’s 2025 Annual Meeting of Shareholders. The Board issued the following statement in response: Over the past three years, the Oportun Board of Directors has overseen decisive and deliberate actions to put the company on a strong path for long-term profitable growth. These actions, which we summarized in our press release on March 20, 2025, have led to improved credit performance, fortified our business economics and driven high-quality originations. Our business momentum and 2025 outlook speak for themselves and are a...

Continue reading

Zelluna ASA [ZLNA]: Key information regarding reverse share split and change of ISIN

Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 9 January 2025 regarding an extraordinary general meeting held in Zelluna ASA (the “Company“), where it was resolved to carry out a reverse share split in the ratio 10:1. Radforsk Investeringsstiftelse has further agreed with the Company to make available, without any compensation a, necessary number of its existing shares to the Company to ensure that all fractions of shares are rounded up to the nearest whole share, thus avoiding that shareholders will have its shareholdings rounded off downwards. Please note the following key information in relation to the reverse share split: – Date on which the corporate action was made public: 19 December 2024 (notice of extraordinary general meeting)– Date of approval: 9 January 2025...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.